- Previous Close
13.25 - Open
13.25 - Bid --
- Ask --
- Day's Range
13.25 - 13.25 - 52 Week Range
13.25 - 13.25 - Volume
100 - Avg. Volume
100 - Market Cap (intraday)
-- - Beta (5Y Monthly) 0.48
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Feb 28, 2025
- 1y Target Est
--
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company was incorporated in 1983 and is headquartered in Richmond, Australia.
www.promed.com.au--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: PMDIY
View MoreCompare To: PMDIY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PMDIY
View MoreValuation Measures
Market Cap
13.07B
Enterprise Value
12.96B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
53.25%
Return on Assets (ttm)
32.90%
Return on Equity (ttm)
51.53%
Revenue (ttm)
184.58M
Net Income Avi to Common (ttm)
98.29M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
182.33M
Total Debt/Equity (mrq)
0.82%
Levered Free Cash Flow (ttm)
84.17M